Search
Resmed Inc
RMDAdd to Watchlist
211.990USD
-11.250-5.04%
Close 08-07 16:00（ET）Quotes delayed by 15 min
307.51BMarket Cap
20.36P/E TTM
More Details of Resmed Inc Company
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Resmed Inc Profile
Ticker SymbolRMD
Company nameResmed Inc
IPO dateJun 01, 1995
CEOFarrell (Michael J)
Number of employees10600
Security typeOrdinary Share
Fiscal year-endJun 01
Address9001 Spectrum Center Blvd
CitySAN DIEGO
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code92123
Phone18587462400
Websitehttps://www.resmed.com/
Ticker SymbolRMD
IPO dateJun 01, 1995
CEOFarrell (Michael J)
Company Executives of Resmed Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%
Dr. Peter C. Farrell, Ph.D.
Dr. Peter C. Farrell, Ph.D.
Founder and Chairman Emeritus
Founder and Chairman Emeritus
--
--
Mr. Brett A. Sandercock
Mr. Brett A. Sandercock
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Jan De Witte
Mr. Jan De Witte
Independent Director
Independent Director
--
--
Mr. Justin M. W. Leong
Mr. Justin M. W. Leong
Chief Product Officer
Chief Product Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. (Mick) Farrell
Mr. Michael J. (Mick) Farrell
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
449.52K
--
Mr. Ronald R. (Ron) Taylor
Mr. Ronald R. (Ron) Taylor
Lead Independent Director
Lead Independent Director
24.77K
+4.33%
Ms. Carol J. Burt
Ms. Carol J. Burt
Independent Director
Independent Director
18.82K
+5.70%
Ms. Harjit Gill
Ms. Harjit Gill
Independent Director
Independent Director
10.94K
+9.46%
Ms. Karen Drexler
Ms. Karen Drexler
Independent Director
Independent Director
10.60K
+10.12%
Dr. Desney Tan
Dr. Desney Tan
Independent Director
Independent Director
6.00K
+17.88%
FAQs
Who are the top five shareholders of Resmed Inc?
The top five shareholders of Resmed Inc are: Mr. Michael J. (Mick) Farrell
How many institutions hold shares of Resmed Inc (RMD)?
As of 2026Q1, 1873 institutions hold shares of Resmed Inc, with a combined market value of approximately 100.10M, accounting for 69.00% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -1407565.00.
What is the biggest source of revenue for Resmed Inc?
In 2026Q1, the Devices business generated the highest revenue for Resmed Inc, amounting to 726.21M and accounting for 51.04% of total revenue.